Patent | Date |
---|
Carrageenan-based Formulations And Associated Methods Of Use App 20080227749 - Place; Virgil A. ;   et al. | 2008-09-18 |
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists Grant 7,226,910 - Wilson , et al. June 5, 2 | 2007-06-05 |
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists App 20060041021 - Wilson; Leland F. ;   et al. | 2006-02-23 |
Carrageenan-based formulations and associated methods of use App 20050239742 - Place, Virgil A. ;   et al. | 2005-10-27 |
Treatment of dyspareunia with topically administered nitroglycerin formulations App 20040044080 - Place, Virgil A. ;   et al. | 2004-03-04 |
Treatment of female sexual dysfunction with phosphodiesterase inhibitors App 20040014761 - Place, Virgil A. ;   et al. | 2004-01-22 |
Treatment of female sexual dysfunction App 20030207852 - Place, Virgil A. ;   et al. | 2003-11-06 |
Transmucosal phosphodiesterase inhibitors for the treatment of erectile dysfunction App 20030134861 - Doherty, Paul C. JR. ;   et al. | 2003-07-17 |
Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction Grant 6,593,313 - Place , et al. July 15, 2 | 2003-07-15 |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Grant 6,548,490 - Doherty, Jr. , et al. April 15, 2 | 2003-04-15 |
Method for minimizing excess collagen deposition Grant 6,472,434 - Place , et al. October 29, 2 | 2002-10-29 |
Treatment of female sexual dysfunction using phosphodiesterase inhibitors Grant 6,469,016 - Place , et al. October 22, 2 | 2002-10-22 |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof App 20020099003 - Wilson, Leland F. ;   et al. | 2002-07-25 |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation Grant 6,403,597 - Wilson , et al. June 11, 2 | 2002-06-11 |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation App 20020037828 - Wilson, Leland F. ;   et al. | 2002-03-28 |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction App 20020004498 - Doherty, Paul C. JR. ;   et al. | 2002-01-10 |
Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction App 20010051656 - Place, Virgil A. ;   et al. | 2001-12-13 |
Treatment of female sexual dysfunction Grant 6,306,841 - Place , et al. October 23, 2 | 2001-10-23 |
Treatment of female sexual dysfunction Grant 6,294,550 - Place , et al. September 25, 2 | 2001-09-25 |
Use of nitric oxide-releasing agents to treat impotency Grant 6,290,981 - Keefer , et al. September 18, 2 | 2001-09-18 |
Buccal drug administration in the treatment of female sexual dysfunction Grant 6,284,263 - Place September 4, 2 | 2001-09-04 |
Compact dosage unit for buccal administration of a pharmacologically active agent Grant 6,284,262 - Place September 4, 2 | 2001-09-04 |
Administration of active agents, including 5-HT receptor agonists and antagonists, to treat premature ejaculation App 20010008896 - Smith, William L. ;   et al. | 2001-07-19 |
Method for facilitating transmucosal delivery of steroidal active agents Grant 6,241,529 - Place June 5, 2 | 2001-06-05 |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation Grant 6,228,864 - Smith , et al. May 8, 2 | 2001-05-08 |
Buccal drug administration in female hormone replacement therapy Grant 6,221,379 - Place April 24, 2 | 2001-04-24 |
Contraceptive method employing buccal delivery of steroidal active agents Grant 6,200,593 - Place March 13, 2 | 2001-03-13 |
Buccal drug delivery system for use in male contraception Grant 6,180,682 - Place January 30, 2 | 2001-01-30 |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction Grant 6,156,753 - Doherty, Jr. , et al. December 5, 2 | 2000-12-05 |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction Grant 6,127,363 - Doherty, Jr. , et al. October 3, 2 | 2000-10-03 |
Drug dosage unit for buccal administration of steroidal active agents Grant 6,117,446 - Place September 12, 2 | 2000-09-12 |
Pharmaceutical compositions for treating priapism and peyronie's syndrome Grant 6,113,939 - Place , et al. September 5, 2 | 2000-09-05 |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Grant 6,037,346 - Doherty, Jr. , et al. March 14, 2 | 2000-03-14 |
Transurethral administration of androgenic agents for the treatment of erectile dysfunction Grant 5,925,629 - Place July 20, 1 | 1999-07-20 |
Local administration of pharmacologically active agents to treat premature ejaculation Grant 5,922,341 - Smith , et al. July 13, 1 | 1999-07-13 |
Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith Grant 5,919,474 - Place , et al. July 6, 1 | 1999-07-06 |
Use of nitric oxide-releasing agents to treat impotency Grant 5,910,316 - Keefer , et al. June 8, 1 | 1999-06-08 |
Treatment of female sexual dysfunction Grant 5,877,216 - Place , et al. March 2, 1 | 1999-03-02 |
Oral osmotic device with hydrogel driving member Grant 5,869,096 - Barclay , et al. February 9, 1 | 1999-02-09 |
Method and kit for preventing erectile dysfunction Grant 5,820,587 - Place October 13, 1 | 1998-10-13 |
Oral osmotic device for delivery of nystatin with hydrogel driving member Grant 5,776,493 - Barclay , et al. July 7, 1 | 1998-07-07 |
Treatment of erectile dysfunction Grant 5,773,020 - Place , et al. June 30, 1 | 1998-06-30 |
Oral osmotic device with hydrogel driving member Grant 5,573,776 - Harrison , et al. November 12, 1 | 1996-11-12 |
Method of treating oral inflammatory disease Grant 5,512,299 - Place , et al. April 30, 1 | 1996-04-30 |
Process for diagnosing erectile dysfunction, and related methods of treatment Grant 5,482,039 - Place January 9, 1 | 1996-01-09 |
Dosage and inserter for treatment of erectile dysfunction Grant 5,474,535 - Place , et al. December 12, 1 | 1995-12-12 |
Oral osmotic device with hydrogel driving member Grant 5,248,310 - Barclay , et al. * September 28, 1 | 1993-09-28 |
Urethral insert for treatment of erectile dysfunction Grant 5,242,391 - Place , et al. September 7, 1 | 1993-09-07 |
Oral osmotic device for delivering nicotine Grant 5,147,654 - Place , et al. September 15, 1 | 1992-09-15 |
Method of signalling a patient during buccal agent delivery Grant 5,053,032 - Barclay , et al. October 1, 1 | 1991-10-01 |
Oral osmotic device with hydrogel driving member Grant 5,021,053 - Barclay , et al. June 4, 1 | 1991-06-04 |
Transdermal drug delivery device Grant 4,867,982 - Campbell , et al. * September 19, 1 | 1989-09-19 |
Transdermal drug delivery device Grant 4,725,439 - Campbell , et al. February 16, 1 | 1988-02-16 |
Self-driven pump assembly and method of operation Grant 4,539,004 - Eckenhoff , et al. September 3, 1 | 1985-09-03 |
Self-driven pump assembly and method of operation Grant 4,474,575 - Eckenhoff , et al. October 2, 1 | 1984-10-02 |
Vaginal contraceptive shield Grant 4,286,593 - Place , et al. September 1, 1 | 1981-09-01 |
Drug delivery device Grant 3,964,482 - Gerstel , et al. June 22, 1 | 1976-06-22 |
Intrauterine device with locator means for indicating uterine position of device Grant 3,902,483 - Place , et al. September 2, 1 | 1975-09-02 |
Device For Dispensing Product With Directional Guidance Member Grant 3,797,492 - Place March 19, 1 | 1974-03-19 |
Hand Held Exercise Device Grant 3,622,152 - Place November 23, 1 | 1971-11-23 |